Koers Wuhan General Group (China), Inc. Other OTC
Aandelen
WUHN
US9825691051
Biotechnologie & Medisch Onderzoek
Omzet 2011 | 128 mln. 119 mln. | Omzet 2012 | 80,38 mln. 75,17 mln. | Marktkapitalisatie | 1,33 mln. 1,25 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2011 | -3 mln. -2,81 mln. | Nettowinst (verlies) 2012 | -10 mln. -9,35 mln. | EV/omzet 2011 | 0,55 x |
Nettoschuld 2011 | 62,49 mln. 58,45 mln. | Nettoschuld 2012 | 100 mln. 93,53 mln. | EV/omzet 2012 | 1,26 x |
K/w-verhouding 2011 |
-1,56
x | K/w-verhouding 2012 |
-0,12
x | Werknemers | - |
Dividendrendement 2011 * |
-
| Dividendrendement 2012 |
-
| Vrij verhandelbaar | 76,65% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Jeff Robinson
FOU | Founder | - | 19-07-88 |
Willem Jonker
DFI | Director of Finance/CFO | - | 05-10-20 |
Riyad Domingo
CTO | Chief Tech/Sci/R&D Officer | - | 01-09-21 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Chief Tech/Sci/R&D Officer | - | 22-01-19 | |
Jeff Robinson
FOU | Founder | - | 19-07-88 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+1,51% | 42,75 mld. | |
+49,22% | 41,61 mld. | |
+8,57% | 41,34 mld. | |
-12,36% | 26,59 mld. | |
+8,92% | 25,49 mld. | |
-25,13% | 18,12 mld. | |
+29,17% | 12,24 mld. | |
-3,12% | 11,76 mld. | |
+6,35% | 11 mld. |